175 related articles for article (PubMed ID: 22659660)
1. [Differential expression of DJ-1 and HSP27 in invasive and non-invasive pituitary adenomas].
Chen W; Shi X; Liu Y; Li C; Xiao Z; Liu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May; 37(5):481-4. PubMed ID: 22659660
[TBL] [Abstract][Full Text] [Related]
2. [The expression of DJ-1 gene in human hepatocellular carcinoma and its relationship with tumor invasion and metastasis].
Wu F; Liang YQ; Huang ZM
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):203-6. PubMed ID: 19335984
[TBL] [Abstract][Full Text] [Related]
3. The expression of integrinbeta1 and FAK in pituitary adenomas and their correlation with invasiveness.
Wang F; Shu K; Lei T; Xue D
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):572-5. PubMed ID: 18846341
[TBL] [Abstract][Full Text] [Related]
4. Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.
Wang M; Zhang H; Heng X; Pang Q; Sun A
Med Sci Monit; 2015 May; 21():1256-60. PubMed ID: 25934796
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
[TBL] [Abstract][Full Text] [Related]
6. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
Kasuki Jomori de Pinho L; Vieira Neto L; Armondi Wildemberg LE; Gasparetto EL; Marcondes J; de Almeida Nunes B; Takiya CM; Gadelha MR
Neuroendocrinology; 2011; 94(1):39-48. PubMed ID: 21178332
[TBL] [Abstract][Full Text] [Related]
7. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
[TBL] [Abstract][Full Text] [Related]
8. Study on the expression levels of CXCR4, CXCL12, CD44, and CD147 and their potential correlation with invasive behaviors of pituitary adenomas.
Xing B; Kong YG; Yao Y; Lian W; Wang RZ; Ren ZY
Biomed Environ Sci; 2013 Jul; 26(7):592-8. PubMed ID: 23895705
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.
Miao Y; Zong M; Jiang T; Yuan X; Guan S; Wang Y; Zhou D
Pituitary; 2016 Apr; 19(2):194-201. PubMed ID: 26809958
[TBL] [Abstract][Full Text] [Related]
10. Expression of MMP14 in invasive pituitary adenomas: relationship to invasion and angiogenesis.
Hui P; Xu X; Xu L; Hui G; Wu S; Lan Q
Int J Clin Exp Pathol; 2015; 8(4):3556-67. PubMed ID: 26097538
[TBL] [Abstract][Full Text] [Related]
11. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
[TBL] [Abstract][Full Text] [Related]
12. DJ-1-induced phosphatase and tensin homologue downregulation is associated with proliferative and invasive activity of laryngeal cancer cells.
Zhu XL; Sun W; Lei WB; Zhuang HW; Hou WJ; Wen WP
Mol Med Rep; 2015 Aug; 12(2):2003-8. PubMed ID: 25892179
[TBL] [Abstract][Full Text] [Related]
13. Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma.
Kong YG; Ren ZY; Su CB; Wang RZ; Ma WB; Lian W
Chin Med Sci J; 2004 Sep; 19(3):199-202. PubMed ID: 15506648
[TBL] [Abstract][Full Text] [Related]
14. The relationship between MRI invasive features and expression of EMMPRIN, galectin-3, and microvessel density in pituitary adenoma.
Zhang Y; He N; Zhou J; Chen Y
Clin Imaging; 2011; 35(3):165-73. PubMed ID: 21513851
[TBL] [Abstract][Full Text] [Related]
15. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
[TBL] [Abstract][Full Text] [Related]
16. Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion.
Mao JH; Guo H; Si N; Qiu L; Guo LF; Sun ZS; Xiang Y; Yang XH; Zhao WG; Zhang WC
Genet Mol Res; 2015 Dec; 14(4):17091-8. PubMed ID: 26681056
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of doublecortin (DCX) in pituitary adenoma.
Liu X; Ma L; Wang Z; Ye J; Liu X; Jiang G; Wang H
Bull Cancer; 2019 Dec; 106(12):1080-1085. PubMed ID: 31376915
[TBL] [Abstract][Full Text] [Related]
18. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast.
Tsuchiya B; Iwaya K; Kohno N; Kawate T; Akahoshi T; Matsubara O; Mukai K
Histopathology; 2012 Jul; 61(1):69-77. PubMed ID: 22385318
[TBL] [Abstract][Full Text] [Related]
20. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
